Sarah Uboldi

1.3k total citations
11 papers, 349 citations indexed

About

Sarah Uboldi is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Cancer Research. According to data from OpenAlex, Sarah Uboldi has authored 11 papers receiving a total of 349 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Pulmonary and Respiratory Medicine, 4 papers in Oncology and 4 papers in Cancer Research. Recurrent topics in Sarah Uboldi's work include Sarcoma Diagnosis and Treatment (9 papers), Peptidase Inhibition and Analysis (3 papers) and Essential Oils and Antimicrobial Activity (1 paper). Sarah Uboldi is often cited by papers focused on Sarcoma Diagnosis and Treatment (9 papers), Peptidase Inhibition and Analysis (3 papers) and Essential Oils and Antimicrobial Activity (1 paper). Sarah Uboldi collaborates with scholars based in Italy, Spain and United Kingdom. Sarah Uboldi's co-authors include Maurizio D’Incalci, Roberta Frapolli, Eugenio Erba, Sergio Marchini, Carlos M. Galmarini, Simonetta Andrea Licandro, Silvia Brich, Roberta Sanfilippo, Luca Beltrame and Ezia Bello and has published in prestigious journals such as PLoS ONE, Oncogene and Clinical Cancer Research.

In The Last Decade

Sarah Uboldi

11 papers receiving 345 citations

Peers

Sarah Uboldi
Sun‐Joo Lee South Korea
Shu Jia China
Junyi Hou China
Yongfeng Jia China
Laura Burdett United States
Zhang Yj China
Elise Pretzsch Germany
Yongfeng He United States
Sun‐Joo Lee South Korea
Sarah Uboldi
Citations per year, relative to Sarah Uboldi Sarah Uboldi (= 1×) peers Sun‐Joo Lee

Countries citing papers authored by Sarah Uboldi

Since Specialization
Citations

This map shows the geographic impact of Sarah Uboldi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sarah Uboldi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sarah Uboldi more than expected).

Fields of papers citing papers by Sarah Uboldi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sarah Uboldi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sarah Uboldi. The network helps show where Sarah Uboldi may publish in the future.

Co-authorship network of co-authors of Sarah Uboldi

This figure shows the co-authorship network connecting the top 25 collaborators of Sarah Uboldi. A scholar is included among the top collaborators of Sarah Uboldi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sarah Uboldi. Sarah Uboldi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Uboldi, Sarah, Ilaria Craparotta, Gennaro Colella, et al.. (2017). Mechanism of action of trabectedin in desmoplastic small round cell tumor cells. BMC Cancer. 17(1). 107–107. 12 indexed citations
2.
Amaral, Ana Teresa, Cecilia Garofalo, Roberta Frapolli, et al.. (2015). Trabectedin Efficacy in Ewing Sarcoma Is Greatly Increased by Combination with Anti-IGF Signaling Agents. Clinical Cancer Research. 21(6). 1373–1382. 36 indexed citations
3.
Uboldi, Sarah, Roberta Frapolli, Simonetta Andrea Licandro, et al.. (2015). Increased sensitivity to platinum drugs of cancer cells with acquired resistance to trabectedin. British Journal of Cancer. 113(12). 1687–1693. 37 indexed citations
4.
Dossi, Romina, Roberta Frapolli, Silvana Di Giandomenico, et al.. (2014). Antiangiogenic activity of trabectedin in myxoid liposarcoma: Involvement of host TIMP‐1 and TIMP‐2 and tumor thrombospondin‐1. International Journal of Cancer. 136(3). 721–729. 48 indexed citations
5.
Uboldi, Sarah, et al.. (2014). Resistance to minor groove binders. Drug Discovery Today Technologies. 11. 73–79. 10 indexed citations
6.
Giandomenico, Silvia Di, Roberta Frapolli, Ezia Bello, et al.. (2013). Mode of action of trabectedin in myxoid liposarcomas. Oncogene. 33(44). 5201–5210. 110 indexed citations
7.
D’Incalci, Maurizio, Sarah Uboldi, Roberta Frapolli, et al.. (2013). Abstract C93: Collateral sensitivity to cisplatin of trabectedin-resistant cell lines.. Molecular Cancer Therapeutics. 12(11_Supplement). C93–C93. 1 indexed citations
8.
Sulaiman, Ghassan M., Ali H. Ad’hiah, Renzo Bagnati, et al.. (2012). Assessing the anti-tumour properties of Iraqi propolis in vitro and in vivo. Food and Chemical Toxicology. 50(5). 1632–1641. 30 indexed citations
9.
Uboldi, Sarah, Enrica Calura, Luca Beltrame, et al.. (2012). A Systems Biology Approach to Characterize the Regulatory Networks Leading to Trabectedin Resistance in an In Vitro Model of Myxoid Liposarcoma. PLoS ONE. 7(4). e35423–e35423. 17 indexed citations
10.
D’Angelo, Daniela, Eleonora Borbone, Dario Palmieri, et al.. (2012). The impairment of the High Mobility Group A (HMGA) protein function contributes to the anticancer activity of trabectedin. European Journal of Cancer. 49(5). 1142–1151. 33 indexed citations
11.
Melø, Torun M., Paolo Bigini, Ursula Sonnewald, et al.. (2010). Neuronal hyperexcitability and seizures are associated with changes in glial–neuronal interactions in the hippocampus of a mouse model of epilepsy with mental retardation. Journal of Neurochemistry. 115(6). 1445–1454. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sun‐Joo Lee Breakdown of academic impact, for papers by Shu Jia Breakdown of academic impact, for papers by Junyi Hou Breakdown of academic impact, for papers by Yongfeng Jia Breakdown of academic impact, for papers by Laura Burdett Breakdown of academic impact, for papers by Zhang Yj Breakdown of academic impact, for papers by Elise Pretzsch Breakdown of academic impact, for papers by Yongfeng He
Rankless by CCL
2026